Ergont en es it fr

Ergont Brand names, Ergont Analogs

Ergont Brand Names Mixture

  • No information avaliable

Ergont Chemical_Formula

C33H37N5O5

Ergont RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Ergont fda sheet

Ergont FDA

Ergont msds (material safety sheet)

Ergont MSDS

Ergont Synthesis Reference

No information avaliable

Ergont Molecular Weight

583.678 g/mol

Ergont Melting Point

No information avaliable

Ergont H2O Solubility

No information avaliable

Ergont State

Solid

Ergont LogP

No information avaliable

Ergont Dosage Forms

Liquid

Ergont Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Ergont Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Ergont Absorption

Interpatient variable and may be dependent on the administration technique

Ergont side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Ergont Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Ergont Organisms Affected

Humans and other mammals